Amgen Sags on Poor REPETHA Results
Amgen (AMGN) is down as clinical trial data for one of its big drugs wasn’t up to expectations. But AMGN still has multiple blockbusters, and a good pipeline.
Amgen (AMGN) is down as clinical trial data for one of its big drugs wasn’t up to expectations. But AMGN still has multiple blockbusters, and a good pipeline.
Visa (V) is flying high due to a number of catalysts, including Visa Europe, Costco, and global economic growth. Let’s review V’s latest qtrly results.
Prime painting season is upon us, and Sherwin Williams (SHW) has the #1 brand in paint, stain, spray paint, and water sealer to fill all your painting needs.
Illinois Tool Works (ITW) just delivered a fantastic qtr, and management said the global economy is heating up. But is ITW too expensive with a P/E of 22?
Johnson & Johnson (JNJ) has grown profits 6% per year the past decade, but its possible the company could grow profits 9% for the third year in a row.
UnitedHealth (UNH) has a lot going for it: strong profit growth, beating estimates, upping future estimates, low P/E, nice yield, safe stock, at new highs.
Factset Research (FDS) provides stock and bond data for guys like me. FDS has been a good stock for a while, so why did it fall after another good qtr?
BlackRock (BLK) is raising assets via its iShares ETFs and passive index funds. Now the firm has its sights on artificial intelligence to manage money.
The Walgreen’s (WBA) Rite Aid merger might not be approved by regulators, but analysts still see 12% profit growth at Walgreen’s the next four qtrs.
McCormick (MKC) is in a slower growth period right now, but profit growth looks to return to the double-digit level later in the year.
Nike (NKE) is down because future orders turned negative last qtr. So is this a good buying opportunity for this Dow stock, or is it time to get out?
Costco (COST) is paying out another big one-time dividend of $7 to shareholders this week — great! But the company missed profit estimates last qtr.